By Ann Saphir AUSTIN, Texas (Reuters) -Federal Reserve Bank of Dallas President Lorie Logan on Thursday said the U.S. central bank appropriately cut rates last month to guard against the risk of a sharp deterioration in the job market, but said that so far the cooling is gradual and signaled she is not eager to …
Fed’s Logan says US central bank must be ‘very cautious’ on rate cuts Read More »
WASHINGTON (Reuters) -U.S. employers announced fewer layoffs in September but hiring plans so far this year were the lowest since 2009, a report said on Thursday, adding to evidence of a labor market standstill as the demand and supply of workers fall because of policy and technology advances. The report from global outplacement firm Challenger, Gray …
US layoffs fall in September but year-to-date planned hiring at lowest in 16 years Read More »
By Fergal Smith TORONTO (Reuters) -The Canadian dollar is set to strengthen over the coming year against its U.S. counterpart as expected Federal Reserve interest rate cuts weigh on the greenback, but uncertain prospects for the United States-Mexico-Canada trade agreement could put that forecast at risk, a Reuters poll found. The median forecast of 38 …
Canadian dollar set to rebound if Fed rate cuts weaken US counterpart: Reuters poll Read More »
(Adjusts title of Fed spokesperson, paragraph 11) By Lananh Nguyen, Nupur Anand, Pete Schroeder and Tatiana Bautzer WASHINGTON (Reuters) -As President Donald Trump’s regulators revamp bank rules, big lenders expect their capital requirements could fall, in a stunning victory for the industry which faced a big hike under former President Joe Biden, according to senior …
US banks expect victory in capital requirements as Trump regulators revamp rules Read More »
(Corrects county exits in 2026 described in paragraph 3 to total 109 from 16, as UnitedHealth clarified an error in the initial figure the company gave.) By Amina Niasse NEW YORK (Reuters) -UnitedHealth said it will stop offering Medicare Advantage plans in 109 U.S. counties in 2026, impacting 180,000 members, as the company balances higher …
UnitedHealth to exit Medicare Advantage plans in 109 US counties Read More »
By Leah Douglas, P.J. Huffstutter and Julie Ingwersen WASHINGTON (Reuters) -The U.S. federal government shutdown that began Wednesday will halt some payments to farmers and delay access to federal farm loans, the latest blow for producers already facing low crop prices, record-high debts and a trade war at the height of the fall harvest. The …
More pain for US farmers as government shutdown halts payments Read More »
By David Morgan, Bo Erickson, Nolan D. McCaskill and Richard Cowan WASHINGTON (Reuters) -U.S. President Donald Trump’s administration on Wednesday froze $26 billion for Democratic-leaning states, following through on a threat to use the government shutdown to target Democratic priorities. The targeted programs included $18 billion for transit projects in New York, home to Congress’s …
White House freezes funds for Democratic states in shutdown slap Read More »
By Pooja Menon and Sheila Dang (Reuters) -Occidental Petroleum will sell its chemicals arm OxyChem to Warren Buffett’s Berkshire Hathaway for $9.7 billion, the company said on Thursday, marking its biggest divestment yet to slash debt after years of costly acquisitions. Shares of the U.S. oil and gas producer, however, fell more than 6% in …
Occidental offloads chemicals unit in $9.7 billion deal with Berkshire to cut debt Read More »
By Lewis Krauskopf NEW YORK (Reuters) -Investors have anticipated for weeks the risks of a U.S. government shutdown to markets. Now that it is here, they are hoping it will be brief. A shutdown that lasts at least several weeks could cause confusion about the Federal Reserve’s monetary policy path as the central bank will …
Analysis-Prolonged US government shutdown could raise market risks Read More »
By Dawn Kopecki, Jarrett Renshaw, Sabrina Valle and Ernest Scheyder NEW YORK, October 2 (Reuters) -Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its cholesterol drug Lipitor; and London-based AstraZeneca to consider a new headquarters in the U.S., according to two sources. Pharmaceutical executives …
Exclusive-Trump targets deals in pharma, AI, energy, mining before midterm elections Read More »
